Highly frequent PIK3CA amplification is associated with poor prognosis in gastric cancer.
about
Gastric biomarkers: a global reviewThe Inositide Signaling Pathway As a Target for Treating Gastric Cancer and Colorectal CancerRecent updates of precision therapy for gastric cancer: Towards optimal tailored managementDiverse mechanisms of AKT pathway activation in human malignancyCIViC databaseThe AKT inhibitor AZD5363 is selectively active in PI3KCA mutant gastric cancer, and sensitizes a patient-derived gastric cancer xenograft model with PTEN loss to Taxotere.Deciphering the link between PI3K and PAK: An opportunity to target key pathways in pancreatic cancer?Variable copy number of mitochondrial DNA (mtDNA) predicts worse prognosis in advanced gastric cancer patients.The Role of PI3K/Akt/mTOR Signaling in Gastric Carcinoma.Pathogenetic mechanisms in gastric cancer.Immunohistochemical molecular phenotypes of gastric cancer based on SOX2 and CDX2 predict patient outcome.Clinical development of phosphatidylinositol 3-kinase inhibitors for cancer treatmentCauses and consequences of microsatellite instability in gastric carcinogenesis.Methylation of ras association domain protein 10 (RASSF10) promoter negative association with the survival of gastric cancer.MET-Amplified Intramucosal Gastric Cancer Widely Metastatic after Complete Endoscopic Submucosal Dissection.PIK3C2G copy number is associated with clinical outcomes of colorectal cancer patients treated with oxaliplatin.Lymphangiogenesis in gastric cancer regulated through Akt/mTOR-VEGF-C/VEGF-D axis.Poor survival is associated with the methylated degree of zinc-finger protein 545 (ZNF545) DNA promoter in gastric cancer.Frequent amplification of PTP1B is associated with poor survival of gastric cancer patientsPIK3CA Amplification Is Common in Left Side-Tubular Adenomas but Uncommon Sessile Serrated Adenomas Exclusively with KRAS Mutation.Frequent amplification of AIB1, a critical oncogene modulating major signaling pathways, is associated with poor survival in gastric cancer.Phosphoinositide-3-kinase, catalytic, alpha polypeptide RNA interference inhibits growth of colon cancer cell SW948.Identifying therapeutic targets in gastric cancer: the current status and future directionDeregulation of ARID1A, CDH1, cMET and PIK3CA and target-related microRNA expression in gastric cancer.The chromosome 3q26 OncCassette: A multigenic driver of human cancer.Akt inhibitor MK-2206 enhances the effect of cisplatin in gastric cancer cells.Mutations in PI3K/AKT pathway genes and amplifications of PIK3CA are associated with patterns of recurrence in gastric cancers.Decreased 5-Hydroxymethylcytosine (5-hmC) predicts poor prognosis in early-stage laryngeal squamous cell carcinoma.Increased expression of EHF via gene amplification contributes to the activation of HER family signaling and associates with poor survival in gastric cancer.Frequent copy number variations of PI3K/AKT pathway and aberrant protein expressions of PI3K subunits are associated with inferior survival in diffuse large B cell lymphoma.In vivo multiplexed interrogation of amplified genes identifies GAB2 as an ovarian cancer oncogene.Low copy number of mitochondrial DNA (mtDNA) predicts worse prognosis in early-stage laryngeal cancer patients.Guidance to rational use of pharmaceuticals in gallbladder sarcomatoid carcinoma using patient-derived cancer cells and whole exome sequencing.Non-invasive imaging of PI3K/Akt/mTOR signalling in cancer.Biomarkers for gastric cancer: prognostic, predictive or targets of therapy?Innovative personalized medicine in gastric cancer: time to move forward.Extracellular vesicles including exosomes are mediators of signal transduction: are they protective or pathogenic?Gastric cancer and gene copy number variation: emerging cancer drivers for targeted therapy.Progression inference for somatic mutations in cancer.Recapitulating Human Gastric Cancer Pathogenesis: Experimental Models of Gastric Cancer.
P2860
Q26741859-D2CDB4B5-3843-4C36-856D-DDC072291894Q26744721-36F2AC8C-23AA-479B-A30C-FB72C5109820Q26746246-7C0D27EB-B12D-4C37-9BC1-AB8EC0466DF6Q26851604-BBA0A546-C038-4BCE-B902-1BA8760DFF3EQ27612411-71845A3F-1DCC-4234-800A-D444301F975BQ27852562-A1672EAD-C4A9-4E28-A039-EF0294E8CFD8Q28079848-83814B36-8487-4AC2-B386-6E68808F83A9Q33589639-E55A4EA6-F524-464E-A266-7EAB6DEA84EBQ34309903-5C067473-86BD-4510-B396-3FF4066E5DE2Q34326627-39FD4C3D-AE38-40D9-81F8-B7AABBAC3EADQ34410160-B4DBD1C6-D2A4-45B3-A3CA-EED731AF4B87Q34508976-594DBD4D-7EC9-42DA-82C8-6D40810AD12EQ34589660-2090B2FB-8068-42F2-BFBD-0FD153A0D0D8Q34704994-5988295E-0BD3-49CC-98E9-819056C122E1Q34977222-224B50CE-9BC5-4B8E-AAEB-910D98437585Q35173768-F158BE38-176F-4296-B435-65F65D5A01ACQ35174365-C362BD23-EDB5-476E-A2E1-00EA5435C480Q35552056-FF89B5C1-09A1-405C-9DD3-EEA72C7B4687Q35565061-98562AA3-3A9B-43D6-BD51-B1C40AF4EF9EQ35651134-59407A31-BCF3-45E9-A072-38AB43398669Q35987349-4B755162-53F3-4CC7-A4CB-72738DC4600BQ36093388-7C190C4C-6ABF-49DA-8349-D9C46BD10343Q36398732-17F1578C-1E32-4332-BBF1-2584FE57B689Q36413660-5FB6AA9D-8319-465F-B5BC-6440C1559D82Q36510237-AE8F64DD-92DA-40D4-95A1-D55B680ADF0AQ36640092-B74B8FB8-65AD-4BAF-993D-DB8FEAA14EBAQ36905878-951962D3-CAF4-44F1-9ED8-DF8A09C66AE2Q36958399-54A21C12-98C7-421A-A824-42E7A0FBECB7Q37465999-B8259545-F725-45B5-8E21-F8FB576A89E4Q37497233-E430B650-B12B-49D5-816E-83D2D6625144Q37519684-F94FAB1D-2791-418E-87D6-9309DA3004E2Q37564494-127D379D-5DA6-43C0-9CF5-65E42180D2B6Q37706353-64D612C8-5A7C-4827-98BF-6477CBC8530EQ38059212-89C65FE0-1735-490B-BC07-1B047E74238DQ38184380-EE1A48F2-9914-4D24-904A-ED090C846731Q38205887-5C62CB21-3E74-4032-9003-F5CDF4F7D21DQ38259278-EFA86028-D148-43C9-9466-A233722ECF61Q38527414-7B541192-2C3C-4B8D-A9F2-121718E52E8CQ38793244-BD8B9CBF-7F25-41F0-9A42-BAB6C712A6A4Q38940560-39404DF0-E749-4FE2-BFEF-AD0B8C56B8B1
P2860
Highly frequent PIK3CA amplification is associated with poor prognosis in gastric cancer.
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Highly frequent PIK3CA amplification is associated with poor prognosis in gastric cancer.
@ast
Highly frequent PIK3CA amplification is associated with poor prognosis in gastric cancer.
@en
Highly frequent PIK3CA amplification is associated with poor prognosis in gastric cancer.
@nl
type
label
Highly frequent PIK3CA amplification is associated with poor prognosis in gastric cancer.
@ast
Highly frequent PIK3CA amplification is associated with poor prognosis in gastric cancer.
@en
Highly frequent PIK3CA amplification is associated with poor prognosis in gastric cancer.
@nl
altLabel
Highly frequent PIK3CA amplification is associated with poor prognosis in gastric cancer
@en
prefLabel
Highly frequent PIK3CA amplification is associated with poor prognosis in gastric cancer.
@ast
Highly frequent PIK3CA amplification is associated with poor prognosis in gastric cancer.
@en
Highly frequent PIK3CA amplification is associated with poor prognosis in gastric cancer.
@nl
P2093
P2860
P3181
P356
P1433
P1476
Highly frequent PIK3CA amplification is associated with poor prognosis in gastric cancer.
@en
P2093
Bingyin Shi
Guanjun Zhang
Hongjun Lv
Nongyue He
P2860
P2888
P3181
P356
10.1186/1471-2407-12-50
P407
P577
2012-02-01T00:00:00Z
P5875
P6179
1008843492